Cargando…

Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity

BACKGROUND: Concurrent diabetes mellitus and tuberculosis represent a significant health problem worldwide. Patients with diabetes mellitus have a high risk of tuberculosis, which may be mediated by an abnormal innate immune response due to hyperglycaemia or low vitamin D levels. METHODS: In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, María Teresa, Gonzalez, Yolanda, Hernández-Sánchez, Fernando, Fabián-San Miguel, Guadalupe, Torres, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590153/
https://www.ncbi.nlm.nih.gov/pubmed/28882103
http://dx.doi.org/10.1186/s12879-017-2705-1
_version_ 1783262479047983104
author Herrera, María Teresa
Gonzalez, Yolanda
Hernández-Sánchez, Fernando
Fabián-San Miguel, Guadalupe
Torres, Martha
author_facet Herrera, María Teresa
Gonzalez, Yolanda
Hernández-Sánchez, Fernando
Fabián-San Miguel, Guadalupe
Torres, Martha
author_sort Herrera, María Teresa
collection PubMed
description BACKGROUND: Concurrent diabetes mellitus and tuberculosis represent a significant health problem worldwide. Patients with diabetes mellitus have a high risk of tuberculosis, which may be mediated by an abnormal innate immune response due to hyperglycaemia or low vitamin D levels. METHODS: In the present study, we evaluated inactive vitamin D serum levels and the monocyte response to infection with M. tuberculosis, including phagocytosis of M. tuberculosis, antimycobacterial activity, LL-37, human β defensin-2 and IL-10 gene expression and nitric oxide production, between type 2 diabetes mellitus patients (n = 51) and healthy volunteers (n = 38). RESULTS: Twenty-seven type 2 diabetes mellitus patients had inadequate inactive vitamin D levels (<50 nM). The percentages of M. tuberculosis phagocytosis between monocytes were similar across groups according to microscopy. Intracellular mycobacterial growth was similar in infected monocytes from both groups. However, M. tuberculosis growth was significantly higher in monocytes obtained from type 2 diabetes mellitus patients and lower vitamin D levels after 1-h (D0) and 72-h (D3) post-infection (p ≤ 0.05). LL-37, human β defensin-2 and IL-10 mRNA expression were similar between monocytes across groups; vitamin D serum levels and LL-37, human β defensin-2 and IL-10 expression were not correlated. Nitric oxide production was significantly higher in healthy volunteers than in type 2 diabetes mellitus patients with low vitamin D serum levels at D3 post-infection (p ≤ 0.05). CONCLUSIONS: Our results show that monocytes from type 2 diabetes mellitus patients and low vitamin D serum levels show an impaired ability to control the intracellular growth of M. tuberculosis, which is not associated with significant decrease of LL-37 or human β defensin-2 expression. Vitamin D could be the link between diabetes and tuberculosis susceptibility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-017-2705-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5590153
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55901532017-09-14 Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity Herrera, María Teresa Gonzalez, Yolanda Hernández-Sánchez, Fernando Fabián-San Miguel, Guadalupe Torres, Martha BMC Infect Dis Research Article BACKGROUND: Concurrent diabetes mellitus and tuberculosis represent a significant health problem worldwide. Patients with diabetes mellitus have a high risk of tuberculosis, which may be mediated by an abnormal innate immune response due to hyperglycaemia or low vitamin D levels. METHODS: In the present study, we evaluated inactive vitamin D serum levels and the monocyte response to infection with M. tuberculosis, including phagocytosis of M. tuberculosis, antimycobacterial activity, LL-37, human β defensin-2 and IL-10 gene expression and nitric oxide production, between type 2 diabetes mellitus patients (n = 51) and healthy volunteers (n = 38). RESULTS: Twenty-seven type 2 diabetes mellitus patients had inadequate inactive vitamin D levels (<50 nM). The percentages of M. tuberculosis phagocytosis between monocytes were similar across groups according to microscopy. Intracellular mycobacterial growth was similar in infected monocytes from both groups. However, M. tuberculosis growth was significantly higher in monocytes obtained from type 2 diabetes mellitus patients and lower vitamin D levels after 1-h (D0) and 72-h (D3) post-infection (p ≤ 0.05). LL-37, human β defensin-2 and IL-10 mRNA expression were similar between monocytes across groups; vitamin D serum levels and LL-37, human β defensin-2 and IL-10 expression were not correlated. Nitric oxide production was significantly higher in healthy volunteers than in type 2 diabetes mellitus patients with low vitamin D serum levels at D3 post-infection (p ≤ 0.05). CONCLUSIONS: Our results show that monocytes from type 2 diabetes mellitus patients and low vitamin D serum levels show an impaired ability to control the intracellular growth of M. tuberculosis, which is not associated with significant decrease of LL-37 or human β defensin-2 expression. Vitamin D could be the link between diabetes and tuberculosis susceptibility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-017-2705-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-07 /pmc/articles/PMC5590153/ /pubmed/28882103 http://dx.doi.org/10.1186/s12879-017-2705-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Herrera, María Teresa
Gonzalez, Yolanda
Hernández-Sánchez, Fernando
Fabián-San Miguel, Guadalupe
Torres, Martha
Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity
title Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity
title_full Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity
title_fullStr Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity
title_full_unstemmed Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity
title_short Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity
title_sort low serum vitamin d levels in type 2 diabetes patients are associated with decreased mycobacterial activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590153/
https://www.ncbi.nlm.nih.gov/pubmed/28882103
http://dx.doi.org/10.1186/s12879-017-2705-1
work_keys_str_mv AT herreramariateresa lowserumvitamindlevelsintype2diabetespatientsareassociatedwithdecreasedmycobacterialactivity
AT gonzalezyolanda lowserumvitamindlevelsintype2diabetespatientsareassociatedwithdecreasedmycobacterialactivity
AT hernandezsanchezfernando lowserumvitamindlevelsintype2diabetespatientsareassociatedwithdecreasedmycobacterialactivity
AT fabiansanmiguelguadalupe lowserumvitamindlevelsintype2diabetespatientsareassociatedwithdecreasedmycobacterialactivity
AT torresmartha lowserumvitamindlevelsintype2diabetespatientsareassociatedwithdecreasedmycobacterialactivity